Recommended Alerts

Sign Up For Alerts

China Proposes Major Changes to Pharmaceutical Regulations

On April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China (Second Draft for Deliberation) (“DAL”) to the Standing Committee of the National People’s Congress of China (the “NPC”) for deliberation.

Read More

China Releases New Essential Drug List

Practices: China Life Sciences

Printer-Friendly Version

Cookie Settings